VIRGINIA RETIREMENT SYSTEMS ET Al Makes New Investment in Avanos Medical, Inc. $AVNS

VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in Avanos Medical, Inc. (NYSE:AVNS) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 15,704 shares of the company’s stock, valued at approximately $192,000.

Several other institutional investors and hedge funds also recently made changes to their positions in AVNS. State of Wyoming grew its stake in Avanos Medical by 104.6% during the first quarter. State of Wyoming now owns 10,508 shares of the company’s stock worth $151,000 after purchasing an additional 5,371 shares during the period. EntryPoint Capital LLC bought a new position in Avanos Medical in the first quarter worth approximately $181,000. EP Wealth Advisors LLC boosted its holdings in Avanos Medical by 46.3% in the first quarter. EP Wealth Advisors LLC now owns 14,783 shares of the company’s stock worth $212,000 after acquiring an additional 4,675 shares in the last quarter. US Bancorp DE boosted its holdings in Avanos Medical by 7.7% in the first quarter. US Bancorp DE now owns 15,184 shares of the company’s stock worth $218,000 after acquiring an additional 1,091 shares in the last quarter. Finally, Cary Street Partners Financial LLC bought a new position in Avanos Medical in the first quarter worth approximately $226,000. Institutional investors and hedge funds own 95.17% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have issued reports on AVNS. Weiss Ratings reiterated a “sell (d-)” rating on shares of Avanos Medical in a report on Tuesday, October 14th. Zacks Research upgraded Avanos Medical to a “hold” rating in a report on Tuesday, August 12th. Finally, Wall Street Zen lowered Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 9th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Avanos Medical presently has an average rating of “Reduce”.

Insider Transactions at Avanos Medical

In other Avanos Medical news, Director Gary Blackford acquired 40,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 13th. The stock was bought at an average price of $10.99 per share, with a total value of $439,600.00. Following the completion of the purchase, the director owned 40,000 shares of the company’s stock, valued at approximately $439,600. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 2.64% of the company’s stock.

Avanos Medical Stock Performance

NYSE:AVNS opened at $11.80 on Monday. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.64 and a quick ratio of 1.58. The business has a fifty day simple moving average of $11.75 and a two-hundred day simple moving average of $11.99. Avanos Medical, Inc. has a 1 year low of $9.30 and a 1 year high of $22.86. The company has a market capitalization of $547.52 million, a P/E ratio of -1.17 and a beta of 1.15.

Avanos Medical (NYSE:AVNS) last released its earnings results on Tuesday, August 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). The firm had revenue of $175.00 million during the quarter, compared to analysts’ expectations of $165.50 million. Avanos Medical had a positive return on equity of 6.16% and a negative net margin of 66.89%.During the same period in the prior year, the business earned $0.34 earnings per share. Avanos Medical has set its FY 2025 guidance at 0.750-0.950 EPS. On average, analysts expect that Avanos Medical, Inc. will post 1.32 earnings per share for the current year.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.